Several Indian companies, including Larsen & Toubro, Godrej Consumer Products, and Dr Reddy’s Laboratories, are expected to record double-digit growth in their topline and bottomline figures for the March quarter due to healthy execution and strong order books. L&T’s core engineering business is expected to drive the topline with a healthy opening order book. Meanwhile, Revlimid, the cancer drug, is expected to have contributed significantly to growth in Dr Reddy’s US sales.
Trump’s ally Elon Musk lost $100 billion, but Warren Buffett gained. What’s he seeing that no one else is?
Warren Buffett and Bill Gates are the only top billionaires to gain wealth in 2025, as global markets slumped. Buffett’s fortune surged by $23 billion,